United States NSAIDs Drug Market Report 2018
![](/report_cover/6975/united-states-nsaids-drug-market-report-2018_qyresearch_en.gif)
In this report, the United States NSAIDs Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
Geographically, this report splits the United States market into seven regions:
- The West
- Southwest
- The Middle Atlantic
- New England
- The South
- The Midwest
- with sales (volume), revenue (value), market share and growth rate of NSAIDs Drug in these regions, from 2013 to 2025 (forecast).
- Pfizer
- GSK
- Grunenthal
- Bayer
- Sanofi
- Eli Lilly
- AstraZeneca
- Endo
- Merck
- Depomed
- Yunnan Baiyao
- Teva
- J&J
- Allergan
- Purdue
- Generic
- Branded
- Hospitals
- Clinics
- Drugstores
United States NSAIDs Drug Market Report 2018
1 NSAIDS DRUG OVERVIEW
1.1 Product Overview and Scope of NSAIDs Drug
1.2 Classification of NSAIDs Drug by Product Category
1.2.1 United States NSAIDs Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States NSAIDs Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Generic
1.2.4 Branded
1.3 United States NSAIDs Drug Market by Application/End Users
1.3.1 United States NSAIDs Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 United States NSAIDs Drug Market by Region
1.4.1 United States NSAIDs Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West NSAIDs Drug Status and Prospect (2013-2025)
1.4.3 Southwest NSAIDs Drug Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic NSAIDs Drug Status and Prospect (2013-2025)
1.4.5 New England NSAIDs Drug Status and Prospect (2013-2025)
1.4.6 The South NSAIDs Drug Status and Prospect (2013-2025)
1.4.7 The Midwest NSAIDs Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of NSAIDs Drug (2013-2025)
1.5.1 United States NSAIDs Drug Sales and Growth Rate (2013-2025)
1.5.2 United States NSAIDs Drug Revenue and Growth Rate (2013-2025)
2 UNITED STATES NSAIDS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS
2.1 United States NSAIDs Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States NSAIDs Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States NSAIDs Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States NSAIDs Drug Market Competitive Situation and Trends
2.4.1 United States NSAIDs Drug Market Concentration Rate
2.4.2 United States NSAIDs Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers NSAIDs Drug Manufacturing Base Distribution, Sales Area, Product Type
3 UNITED STATES NSAIDS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)
3.1 United States NSAIDs Drug Sales and Market Share by Region (2013-2018)
3.2 United States NSAIDs Drug Revenue and Market Share by Region (2013-2018)
3.3 United States NSAIDs Drug Price by Region (2013-2018)
4 UNITED STATES NSAIDS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)
4.1 United States NSAIDs Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States NSAIDs Drug Revenue and Market Share by Type (2013-2018)
4.3 United States NSAIDs Drug Price by Type (2013-2018)
4.4 United States NSAIDs Drug Sales Growth Rate by Type (2013-2018)
5 UNITED STATES NSAIDS DRUG SALES (VOLUME) BY APPLICATION (2013-2018)
5.1 United States NSAIDs Drug Sales and Market Share by Application (2013-2018)
5.2 United States NSAIDs Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 UNITED STATES NSAIDS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 NSAIDs Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 GSK
6.2.2 NSAIDs Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GSK NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Grunenthal
6.3.2 NSAIDs Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Grunenthal NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bayer
6.4.2 NSAIDs Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bayer NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.2 NSAIDs Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Eli Lilly
6.6.2 NSAIDs Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eli Lilly NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 AstraZeneca
6.7.2 NSAIDs Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AstraZeneca NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Endo
6.8.2 NSAIDs Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Endo NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 NSAIDs Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Depomed
6.10.2 NSAIDs Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Depomed NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Yunnan Baiyao
6.12 Teva
6.13 J&J
6.14 Allergan
6.15 Purdue
7 NSAIDS DRUG MANUFACTURING COST ANALYSIS
7.1 NSAIDs Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of NSAIDs Drug
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 NSAIDs Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of NSAIDs Drug Major Manufacturers in 2017
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES NSAIDS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)
11.1 United States NSAIDs Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States NSAIDs Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States NSAIDs Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States NSAIDs Drug Sales Volume Forecast by Region (2018-2025)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 NSAIDS DRUG OVERVIEW
1.1 Product Overview and Scope of NSAIDs Drug
1.2 Classification of NSAIDs Drug by Product Category
1.2.1 United States NSAIDs Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States NSAIDs Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Generic
1.2.4 Branded
1.3 United States NSAIDs Drug Market by Application/End Users
1.3.1 United States NSAIDs Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 United States NSAIDs Drug Market by Region
1.4.1 United States NSAIDs Drug Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West NSAIDs Drug Status and Prospect (2013-2025)
1.4.3 Southwest NSAIDs Drug Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic NSAIDs Drug Status and Prospect (2013-2025)
1.4.5 New England NSAIDs Drug Status and Prospect (2013-2025)
1.4.6 The South NSAIDs Drug Status and Prospect (2013-2025)
1.4.7 The Midwest NSAIDs Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of NSAIDs Drug (2013-2025)
1.5.1 United States NSAIDs Drug Sales and Growth Rate (2013-2025)
1.5.2 United States NSAIDs Drug Revenue and Growth Rate (2013-2025)
2 UNITED STATES NSAIDS DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS
2.1 United States NSAIDs Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States NSAIDs Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States NSAIDs Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States NSAIDs Drug Market Competitive Situation and Trends
2.4.1 United States NSAIDs Drug Market Concentration Rate
2.4.2 United States NSAIDs Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers NSAIDs Drug Manufacturing Base Distribution, Sales Area, Product Type
3 UNITED STATES NSAIDS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)
3.1 United States NSAIDs Drug Sales and Market Share by Region (2013-2018)
3.2 United States NSAIDs Drug Revenue and Market Share by Region (2013-2018)
3.3 United States NSAIDs Drug Price by Region (2013-2018)
4 UNITED STATES NSAIDS DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)
4.1 United States NSAIDs Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States NSAIDs Drug Revenue and Market Share by Type (2013-2018)
4.3 United States NSAIDs Drug Price by Type (2013-2018)
4.4 United States NSAIDs Drug Sales Growth Rate by Type (2013-2018)
5 UNITED STATES NSAIDS DRUG SALES (VOLUME) BY APPLICATION (2013-2018)
5.1 United States NSAIDs Drug Sales and Market Share by Application (2013-2018)
5.2 United States NSAIDs Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 UNITED STATES NSAIDS DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 NSAIDs Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 GSK
6.2.2 NSAIDs Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GSK NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Grunenthal
6.3.2 NSAIDs Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Grunenthal NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bayer
6.4.2 NSAIDs Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bayer NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.2 NSAIDs Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Eli Lilly
6.6.2 NSAIDs Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Eli Lilly NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 AstraZeneca
6.7.2 NSAIDs Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AstraZeneca NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Endo
6.8.2 NSAIDs Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Endo NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 NSAIDs Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Depomed
6.10.2 NSAIDs Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Depomed NSAIDs Drug Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Yunnan Baiyao
6.12 Teva
6.13 J&J
6.14 Allergan
6.15 Purdue
7 NSAIDS DRUG MANUFACTURING COST ANALYSIS
7.1 NSAIDs Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of NSAIDs Drug
8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 NSAIDs Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of NSAIDs Drug Major Manufacturers in 2017
8.4 Downstream Buyers
9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 UNITED STATES NSAIDS DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)
11.1 United States NSAIDs Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States NSAIDs Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States NSAIDs Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States NSAIDs Drug Sales Volume Forecast by Region (2018-2025)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Product Picture of NSAIDs Drug
Figure United States NSAIDs Drug Market Size (K Units) by Type (2013-2025)
Figure United States NSAIDs Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Generic Product Picture
Figure Branded Product Picture
Figure United States NSAIDs Drug Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of NSAIDs Drug by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Drugstores Examples
Table Key Downstream Customer in Drugstores
Figure United States NSAIDs Drug Market Size (Million USD) by Region (2013-2025)
Figure The West NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States NSAIDs Drug Sales (K Units) and Growth Rate (2013-2025)
Figure United States NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States NSAIDs Drug Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States NSAIDs Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States NSAIDs Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States NSAIDs Drug Sales Share by Players/Suppliers
Figure 2017 United States NSAIDs Drug Sales Share by Players/Suppliers
Figure United States NSAIDs Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States NSAIDs Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States NSAIDs Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States NSAIDs Drug Revenue Share by Players/Suppliers
Figure 2017 United States NSAIDs Drug Revenue Share by Players/Suppliers
Table United States Market NSAIDs Drug Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market NSAIDs Drug Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States NSAIDs Drug Market Share of Top 3 Players/Suppliers
Figure United States NSAIDs Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers NSAIDs Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers NSAIDs Drug Product Category
Table United States NSAIDs Drug Sales (K Units) by Region (2013-2018)
Table United States NSAIDs Drug Sales Share by Region (2013-2018)
Figure United States NSAIDs Drug Sales Share by Region (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Region in 2017
Table United States NSAIDs Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States NSAIDs Drug Revenue Share by Region (2013-2018)
Figure United States NSAIDs Drug Revenue Market Share by Region (2013-2018)
Figure United States NSAIDs Drug Revenue Market Share by Region in 2017
Table United States NSAIDs Drug Price (USD/Unit) by Region (2013-2018)
Table United States NSAIDs Drug Sales (K Units) by Type (2013-2018)
Table United States NSAIDs Drug Sales Share by Type (2013-2018)
Figure United States NSAIDs Drug Sales Share by Type (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Type in 2017
Table United States NSAIDs Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States NSAIDs Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of NSAIDs Drug by Type (2013-2018)
Figure Revenue Market Share of NSAIDs Drug by Type in 2017
Table United States NSAIDs Drug Price (USD/Unit) by Types (2013-2018)
Figure United States NSAIDs Drug Sales Growth Rate by Type (2013-2018)
Table United States NSAIDs Drug Sales (K Units) by Application (2013-2018)
Table United States NSAIDs Drug Sales Market Share by Application (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Application (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Application in 2017
Table United States NSAIDs Drug Sales Growth Rate by Application (2013-2018)
Figure United States NSAIDs Drug Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Pfizer NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Pfizer NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK NSAIDs Drug Sales Growth Rate (2013-2018)
Figure GSK NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure GSK NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Grunenthal Basic Information List
Table Grunenthal NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grunenthal NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Grunenthal NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Grunenthal NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Bayer NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Bayer NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Sanofi NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Sanofi NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Eli Lilly NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca NSAIDs Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure AstraZeneca NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Endo Basic Information List
Table Endo NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Endo NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Endo NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Endo NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Merck NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Merck NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Depomed Basic Information List
Table Depomed NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Depomed NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Depomed NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Depomed NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Yunnan Baiyao Basic Information List
Table Teva Basic Information List
Table J&J Basic Information List
Table Allergan Basic Information List
Table Purdue Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of NSAIDs Drug
Figure Manufacturing Process Analysis of NSAIDs Drug
Figure NSAIDs Drug Industrial Chain Analysis
Table Raw Materials Sources of NSAIDs Drug Major Players/Suppliers in 2017
Table Major Buyers of NSAIDs Drug
Table Distributors/Traders List
Figure United States NSAIDs Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States NSAIDs Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States NSAIDs Drug Price (USD/Unit) Trend Forecast (2018-2025)
Table United States NSAIDs Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Type in 2025
Table United States NSAIDs Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Application in 2025
Table United States NSAIDs Drug Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States NSAIDs Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States NSAIDs Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States NSAIDs Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Product Picture of NSAIDs Drug
Figure United States NSAIDs Drug Market Size (K Units) by Type (2013-2025)
Figure United States NSAIDs Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Generic Product Picture
Figure Branded Product Picture
Figure United States NSAIDs Drug Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of NSAIDs Drug by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Drugstores Examples
Table Key Downstream Customer in Drugstores
Figure United States NSAIDs Drug Market Size (Million USD) by Region (2013-2025)
Figure The West NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States NSAIDs Drug Sales (K Units) and Growth Rate (2013-2025)
Figure United States NSAIDs Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States NSAIDs Drug Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States NSAIDs Drug Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States NSAIDs Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States NSAIDs Drug Sales Share by Players/Suppliers
Figure 2017 United States NSAIDs Drug Sales Share by Players/Suppliers
Figure United States NSAIDs Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States NSAIDs Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States NSAIDs Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States NSAIDs Drug Revenue Share by Players/Suppliers
Figure 2017 United States NSAIDs Drug Revenue Share by Players/Suppliers
Table United States Market NSAIDs Drug Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market NSAIDs Drug Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States NSAIDs Drug Market Share of Top 3 Players/Suppliers
Figure United States NSAIDs Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers NSAIDs Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers NSAIDs Drug Product Category
Table United States NSAIDs Drug Sales (K Units) by Region (2013-2018)
Table United States NSAIDs Drug Sales Share by Region (2013-2018)
Figure United States NSAIDs Drug Sales Share by Region (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Region in 2017
Table United States NSAIDs Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States NSAIDs Drug Revenue Share by Region (2013-2018)
Figure United States NSAIDs Drug Revenue Market Share by Region (2013-2018)
Figure United States NSAIDs Drug Revenue Market Share by Region in 2017
Table United States NSAIDs Drug Price (USD/Unit) by Region (2013-2018)
Table United States NSAIDs Drug Sales (K Units) by Type (2013-2018)
Table United States NSAIDs Drug Sales Share by Type (2013-2018)
Figure United States NSAIDs Drug Sales Share by Type (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Type in 2017
Table United States NSAIDs Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States NSAIDs Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of NSAIDs Drug by Type (2013-2018)
Figure Revenue Market Share of NSAIDs Drug by Type in 2017
Table United States NSAIDs Drug Price (USD/Unit) by Types (2013-2018)
Figure United States NSAIDs Drug Sales Growth Rate by Type (2013-2018)
Table United States NSAIDs Drug Sales (K Units) by Application (2013-2018)
Table United States NSAIDs Drug Sales Market Share by Application (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Application (2013-2018)
Figure United States NSAIDs Drug Sales Market Share by Application in 2017
Table United States NSAIDs Drug Sales Growth Rate by Application (2013-2018)
Figure United States NSAIDs Drug Sales Growth Rate by Application (2013-2018)
Table Pfizer Basic Information List
Table Pfizer NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Pfizer NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Pfizer NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK NSAIDs Drug Sales Growth Rate (2013-2018)
Figure GSK NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure GSK NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Grunenthal Basic Information List
Table Grunenthal NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grunenthal NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Grunenthal NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Grunenthal NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Bayer NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Bayer NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Sanofi NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Sanofi NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Eli Lilly NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Eli Lilly NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca NSAIDs Drug Sales Growth Rate (2013-2018)
Figure AstraZeneca NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure AstraZeneca NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Endo Basic Information List
Table Endo NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Endo NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Endo NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Endo NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Merck NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Merck NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Depomed Basic Information List
Table Depomed NSAIDs Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Depomed NSAIDs Drug Sales Growth Rate (2013-2018)
Figure Depomed NSAIDs Drug Sales Market Share in United States (2013-2018)
Figure Depomed NSAIDs Drug Revenue Market Share in United States (2013-2018)
Table Yunnan Baiyao Basic Information List
Table Teva Basic Information List
Table J&J Basic Information List
Table Allergan Basic Information List
Table Purdue Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of NSAIDs Drug
Figure Manufacturing Process Analysis of NSAIDs Drug
Figure NSAIDs Drug Industrial Chain Analysis
Table Raw Materials Sources of NSAIDs Drug Major Players/Suppliers in 2017
Table Major Buyers of NSAIDs Drug
Table Distributors/Traders List
Figure United States NSAIDs Drug Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States NSAIDs Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States NSAIDs Drug Price (USD/Unit) Trend Forecast (2018-2025)
Table United States NSAIDs Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Type in 2025
Table United States NSAIDs Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States NSAIDs Drug Sales Volume (K Units) Forecast by Application in 2025
Table United States NSAIDs Drug Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States NSAIDs Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States NSAIDs Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States NSAIDs Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources